Participation of Opioid Receptors in the Cytoprotective Effect ofChronic Normobaric Hypoxia; Physiological Research; Vol. 68, iss. 2
| Parent link: | Physiological Research Vol. 68, iss. 2.— 2019.— [P. 245-253] |
|---|---|
| Співавтор: | Национальный исследовательский Томский политехнический университет Физико-технический институт Лаборатория № 31 ядерного реактора |
| Інші автори: | Naryzhnaya N. V. Nataliya Vladimirovna, Khaliulin I. G. Igor Grigorjevich, Lishmanov Yu. B. Yury Borisovich, Suleiman M. S. Saadeh, Tsybulnikov S. Yu. Sergey Yurjevich, Kolar F. Frantisek, Maslov L. N. Leonid Nikolaevich |
| Резюме: | Title screen We studied the role of the δ, µ, and к opioid receptor (OR) subtypes in the cardioprotective effect of chronic continuous normobaric hypoxia (CNH) in the model of acuteanoxia/ reoxygenation of isolated cardiomyocytes. Adaptation of rats to CNH was performed by their exposure to atmosphere containing 12 % of O2 for 21 days. Anoxia/reoxygenation of cardiomyocytes isolated from normoxic control rats caused the death of 51 % of cells and lactate dehydrogenase (LDH) release. Adaptation of rats to CNH resulted in the anoxia/reoxygenation-induced cardiomyocyte death of only 38 %, and reduced the LDH release. Pre-incubation of the cells with either the non-selective OR blocker naloxone (300 nM/l), the δ OR antagonist TIPP(ψ) (30 nM/l), the selective δ2 OR antagonist naltriben (1 nM/l) or the μ OR antagonist CTAP (100 nM/l) for 25 minutes before anoxia abolished the reduction of cell death and LDH release afforded by CNH. The antagonist of δ1 OR BNTX (1 nM/l) or the κ OR antagonist nor-binaltorphimine (3 nM/l) did not influence the cytoprotective effects of CNH. Taken together, the cytoprotective effect of CNH is associated with the activation of the δ2 and μ OR localized on cardiomyocytes |
| Мова: | Англійська |
| Опубліковано: |
2019
|
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.33549/physiolres.933938 |
| Формат: | Електронний ресурс Частина з книги |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=663260 |
Схожі ресурси
The Role of Cardiac Opioid Receptors in the Cardioprotective Effect of Continuous Normobaric Hypoxia; Bulletin of Experimental Biology and Medicine; Vol. 168, iss. 6
Опубліковано: (2020)
Опубліковано: (2020)
Effect of Chronic Continuous Normobaric Hypoxia on Functional State of Cardiac Mitochondria and Tolerance of Isolated Rat Heart to Ischemia and Reperfusion: Role of µ and delta2 Opioid Receptors; Physiological Research; Vol. 68, iss. 6
Опубліковано: (2019)
Опубліковано: (2019)
Continuous Normobaric Hypoxia Improved Cardiac Bioenergetics after Ischemia/Reperfusion: Role of Opioid Receptors; Bulletin of Experimental Biology and Medicine; Vol. 169, iss. 1
Опубліковано: (2020)
Опубліковано: (2020)
Cardioprotective Properties of Opioid Receptor Agonists in Rats WithStress-Induced Cardiac Injury; Physiological Research; Vol. 68, iss. 3
Опубліковано: (2019)
Опубліковано: (2019)
Role of protein kinase C, PI3 kinase, tyrosine kinases, NO-synthase, KATP channels and MPT pore in the signaling pathway of the cardioprotective effect of chronic continuous hypoxia; General Physiology and Biophysics; Vol. 37, iss. 5
Опубліковано: (2018)
Опубліковано: (2018)
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists; Medicinal Research Reviews; Vol. 36, iss. 5
Опубліковано: (2016)
Опубліковано: (2016)
Cardiac Autonomic and Physiological Responses to Moderate- intensity Exercise in Hypoxia; International Journal of Sports Medicine; Vol. 40, iss. 14
Опубліковано: (2019)
Опубліковано: (2019)
Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion; Journal of Evolutionary Biochemistry and Physiology; Vol. 59, iss. 3
Опубліковано: (2023)
Опубліковано: (2023)
Delayed parasympathetic reactivation and sympathetic withdrawal following maximal cardiopulmonary exercise testing (CPET) in hypoxia; European Journal of Applied Physiology; Vol. 118, iss. 10
Опубліковано: (2018)
Опубліковано: (2018)
Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure; Heart Failure Reviews; Vol. 2017
Опубліковано: (2017)
Опубліковано: (2017)
Chronic toxicity of shrimp feed added with silver nanoparticles (Argovit-4®) in Litopenaeus vannamei and immune response to white spot syndrome virus infection; PeerJ; Vol. 10
Опубліковано: (2022)
Опубліковано: (2022)
Opioid Receptors Methods and Protocols /
Опубліковано: (2015)
Опубліковано: (2015)
Opioid Receptors Methods and Protocols /
Опубліковано: (2021)
Опубліковано: (2021)
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors; The World Journal of Biological Psychiatry; Latest Articles
Опубліковано: (2018)
Опубліковано: (2018)
A novel urea derivative anticonvulsant: In vivo biological evaluation, radioreceptor analysis of GABAA receptors and molecular docking studies of enantiomers; Mendeleev Communications; Vol. 33, iss. 4
Опубліковано: (2023)
Опубліковано: (2023)
Post-exercise cardiac autonomic and cardiovascular responses to heart rate-matched and work rate-matched hypoxic exercise; European Journal of Applied Physiology; Vol. 121
Опубліковано: (2021)
Опубліковано: (2021)
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis; Molecules; Vol. 26, iss. 21
Опубліковано: (2021)
Опубліковано: (2021)
Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal Offenders; Neuropsychobiology; Vol. 75, iss. 4
Опубліковано: (2017)
Опубліковано: (2017)
Shortening Work-Rest Durations Reduces Physiological and Perceptual Load during Uphill Walking in Simulated Cold High-Altitude Conditions; High Altitude Medicine and Biology; Vol. 21, iss. 3
Опубліковано: (2020)
Опубліковано: (2020)
Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression; Frontiers in Pharmacology; Vol. 10
Опубліковано: (2019)
Опубліковано: (2019)
4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists; Biochemical Pharmacology; Vol. 142
Опубліковано: (2017)
Опубліковано: (2017)
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8; Pharmaceutics; Vol. 17, iss. 8
Опубліковано: (2025)
Опубліковано: (2025)
Immunotoxicity Study of Cucurbit[n]urils (n = 6, 7, 8) and Modeling of Interaction with Some Monocyte Receptors by a Molecular Docking Method; Molecules; Vol. 30, iss. 10
Опубліковано: (2025)
Опубліковано: (2025)
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists; Chemical Biology and Drug Design; Vol. 98, iss. 4
Опубліковано: (2021)
Опубліковано: (2021)
Inhibition of T Cell Receptor Activation by Semi-Synthetic Sesquiterpene Lactone Derivatives and Molecular Modeling of Their Interaction with Glutathione and Tyrosine Kinase ZAP-70; Molecules; Vol. 24, iss. 2
Опубліковано: (2019)
Опубліковано: (2019)
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer; Pharmaceutics; Vol. 12, iss. 10
Опубліковано: (2020)
Опубліковано: (2020)
Влияние нативных гуминовых кислот низинного торфа Томской области на окислительное фосфорилирование в митохондриях в условиях гипоксии; Химико-фармацевтический журнал; Т. 49, № 4
Опубліковано: (2015)
Опубліковано: (2015)
Channeling and PXR experiments at the SAGA light source; RReps'11. Radiation from Relativistic Electrons in Periodic Structures
Опубліковано: (2011)
Опубліковано: (2011)
A review of surface-enhanced Raman spectroscopy in pathological processes; Analytica Chimica Acta; Vol. 1187
Опубліковано: (2021)
Опубліковано: (2021)
Опыт реабилитации детей с хроническим пиелонефритом в условиях промышленного города; Сибирский журнал клинической и экспериментальной медицины; Т. 36, № 2
Опубліковано: (2021)
Опубліковано: (2021)
The original anticonvulsant meta-Cl-benzhydrylurea (m-CL-BHM) induces of the liver monooxygenase system and stimulates the neuroimmune response in behavioral disorders of alcoholic origin; European Psychiatry; Vol. 65, Special iss. S1 : Abstracts of the 30th European Congress of Psychiatry, June 2022
Опубліковано: (2022)
Опубліковано: (2022)
Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer; EJNMMI Research; Vol. 10, iss. 1
Опубліковано: (2020)
Опубліковано: (2020)
Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model; Cancers; Vol. 13, iss. 1
Опубліковано: (2020)
Опубліковано: (2020)
Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer; Molecules; Vol. 25, iss. 24
Опубліковано: (2020)
Опубліковано: (2020)
Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity; Molecules; Vol. 27, iss. 12
Опубліковано: (2022)
Опубліковано: (2022)
Hypoxia Methods and Protocols /
Опубліковано: (2024)
Опубліковано: (2024)
Hypoxia Methods and Protocols /
Опубліковано: (2018)
Опубліковано: (2018)
Limitation of Maximal Heart Rate in Hypoxia: Mechanisms and Clinical Importance; Frontiers in Physiology; Vol. 9
за авторством: Mourot L. Laurent
Опубліковано: (2018)
за авторством: Mourot L. Laurent
Опубліковано: (2018)
A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia; BMC Medical Genetics; Vol. 20
Опубліковано: (2019)
Опубліковано: (2019)
Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer; Pharmaceutics; Vol. 13, iss. 2
Опубліковано: (2021)
Опубліковано: (2021)
Схожі ресурси
-
The Role of Cardiac Opioid Receptors in the Cardioprotective Effect of Continuous Normobaric Hypoxia; Bulletin of Experimental Biology and Medicine; Vol. 168, iss. 6
Опубліковано: (2020) -
Effect of Chronic Continuous Normobaric Hypoxia on Functional State of Cardiac Mitochondria and Tolerance of Isolated Rat Heart to Ischemia and Reperfusion: Role of µ and delta2 Opioid Receptors; Physiological Research; Vol. 68, iss. 6
Опубліковано: (2019) -
Continuous Normobaric Hypoxia Improved Cardiac Bioenergetics after Ischemia/Reperfusion: Role of Opioid Receptors; Bulletin of Experimental Biology and Medicine; Vol. 169, iss. 1
Опубліковано: (2020) -
Cardioprotective Properties of Opioid Receptor Agonists in Rats WithStress-Induced Cardiac Injury; Physiological Research; Vol. 68, iss. 3
Опубліковано: (2019) -
Role of protein kinase C, PI3 kinase, tyrosine kinases, NO-synthase, KATP channels and MPT pore in the signaling pathway of the cardioprotective effect of chronic continuous hypoxia; General Physiology and Biophysics; Vol. 37, iss. 5
Опубліковано: (2018)